|
🐜
|
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
27 auth.
C. Steidl,
Sohrab P. Shah,
B. Woolcock,
L. Rui,
M. Kawahara,
P. Farinha,
N. Johnson,
Yongjun Zhao,
A. Telenius,
S. B. Neriah,
A. McPherson,
B. Meissner,
Ujunwa C. Okoye,
A. Diepstra,
A. Berg,
...
Mark G. F. Sun,
G. Leung,
Steven J. M. Jones,
J. Connors,
D. Huntsman,
K. Savage,
L. Rimsza,
D. Horsman,
L. Staudt,
U. Steidl,
M. Marra,
R. Gascoyne
|
9 |
2011 |
9
🐜
|
|
🐜
|
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
64 auth.
K. Urayama,
R. Jarrett,
H. Hjalgrim,
A. Diepstra,
Y. Kamatani,
Amélie Chabrier,
V. Gaborieau,
A. Boland,
A. Nieters,
N. Becker,
L. Foretova,
Y. Benavente,
M. Maynadié,
A. Staines,
Lesley A. Shield,
...
Annette Lake,
Dorothy Montgomery,
Malcolm Taylor,
K. Smedby,
R. Amini,
H. Adami,
H. Adami,
B. Glimelius,
B. Feenstra,
I. Nolte,
L. Visser,
G. V. Imhoff,
T. Lightfoot,
P. Cocco,
Lambertus Kiemeney,
S. Vermeulen,
I. Holcatova,
L. Vatten,
G. Macfarlane,
P. Thomson,
D. Conway,
S. Benhamou,
A. Agudo,
C. Healy,
K. Overvad,
A. Tjønneland,
B. Melin,
F. Canzian,
K. Khaw,
R. Travis,
P. Peeters,
C. González,
J. Quirós,
M. Sanchez,
J. Huerta,
E. Ardanaz,
M. Dorronsoro,
F. Clavel-Chapelon,
H. Bueno-de-Mesquita,
E. Riboli,
E. Roman,
P. Boffetta,
S. Sanjosé,
D. Zélénika,
M. Melbye,
A. Berg,
M. Lathrop,
P. Brennan,
J. Mckay
|
7 |
2012 |
7
🐜
|
|
🐜
|
Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients
22 auth.
Rubina Koppers-Lalic,
Danijela van der Voorn,
Hans Libregts,
Sten F W M Wauben,
M. MarcaH,
M. V. Eijndhoven,
J. Zijlstra,
Nils J. Groenewegen,
E. Drees,
Stuart van Niele,
...
S. R. Baglio,
Danijela Koppers-Lalic,
H. V. D. Voorn,
S. Libregts,
M. Wauben,
R. X. Menezes,
J. Weering,
R. Nieuwland,
L. Visser,
A. Berg,
D. D. Jong,
M. Pegtel
|
7 |
2016 |
7
🐜
|
|
🐜
|
Long noncoding RNAs as a novel component of the Myc transcriptional network
11 auth.
Melanie Winkle,
A. Berg,
M. Tayari,
Jantine G. Sietzema,
M. Terpstra,
Gertrud Kortman,
...
D. Jong,
L. Visser,
A. Diepstra,
K. Kok,
J. Kluiver
|
5 |
2015 |
5
🐜
|
|
🐢
|
High expression of calcium‐binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma
12 auth.
R. Rust,
L. Visser,
J. Leij,
G. Harms,
T. Blokzijl,
J. Deloulme,
...
P. Vlies,
W. Kamps,
K. Kok,
M. Lim,
S. Poppema,
A. Berg
|
5 |
2005 |
5
🐢
|
|
🐢
|
Emerging roles for long noncoding RNAs in B-cell development and malignancy.
Melanie Winkle,
J. Kluiver,
A. Diepstra,
A. Berg
|
5 |
2017 |
5
🐢
|
|
🐜
|
Production of hemopexin by TNF-α stimulated human mesangial cells
7 auth.
J. Kapojos,
A. Berg,
H. Goor,
M. T. Loo,
K. Poelstra,
T. Borghuis,
...
W. Bakker
|
4 |
2003 |
4
🐜
|
|
🐬
|
Composite Lymphoma: EBV-positive Classic Hodgkin Lymphoma and Peripheral T-cell Lymphoma: A Case Report
G. Gualco,
L. Chioato,
A. Berg,
L. Weiss,
C. Bacchi
|
4 |
2009 |
4
🐬
|
|
🐜
|
Argonaute 2 immunoprecipitation revealed large tumor suppressor kinase 1 as a novel proapoptotic target of miR‐21 in T cells
14 auth.
Nato Teteloshvili,
K. Śmigielska-Czepiel,
Ye Yuan,
Annika Seitz,
D. Jong,
B. Rutgers,
P. Jellema,
Roelof Jan Lei,
I. Ślęzak-Prochazka,
E. Brouwer,
...
A. Boots,
B. Kroesen,
A. Berg,
J. Kluiver
|
3 |
2017 |
3
🐜
|
|
🐜
|
Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients
7 auth.
W. Plattel,
A. Berg,
A. V. D. Graaf,
Hans Yos,
L. Visser,
A. Diepstra,
...
G. V. Imhoff
|
2 |
2010 |
2
🐜
|
